High Mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia
- 12 January 2006
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 20 (3) , 498-504
- https://doi.org/10.1038/sj.leu.2404073
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Chronic lymphocytic leukemia: revelations from the B-cell receptorBlood, 2004
- Class II cytokine receptors and their ligands: Key antiviral and inflammatory modulatorsNature Reviews Immunology, 2003
- Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspasesLeukemia, 2003
- Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 productionBlood, 2002
- B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytesBlood, 2002
- Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27Leukemia, 2002
- Interaction of the CD5 cytoplasmic domain with the Ca2+ /calmodulin-dependent kinase IIδEuropean Journal of Immunology, 1998
- Regulation of Casein Kinase 2 by Direct Interaction with Cell Surface Receptor CD5Published by Elsevier ,1998
- CD5-Mediated Negative Regulation of Antigen Receptor-Induced Growth Signals in B-1 B CellsScience, 1996
- Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 1995